Part 1 | Wednesday, July 31, 2024, Pre-Assessment

Please enable JavaScript in your browser to complete this form.
1. Which of the following comorbidities is most commonly experienced among patients with obesity?
2. Your 44-year-old patient with a BMI of 36 kg/m2 presents to the clinic for an annual visit. She has a history of dyslipidemia and hypertension. What % weight loss is needed to see a therapeutic benefit in her hypertension?
3. Which of the following is true regarding the second-generation anti-obesity medications (AOMs) semaglutide and tirzepatide?
Scroll to Top